@FierceBiotech: Cancer drug collaborations are hot. Story | Follow @FierceBiotech
@JohnCFierce: Interesting Xconomy piece on Somnus, but de-risked sleep meds relying on new delivery tech just looks weak to me. News | Follow @JohnCFierce
> George Scangos, the new CEO at Biogen Idec, has made no secret of his desire to reunite his headquarters team with its Cambridge R&D ops. In an interview with Xconomy, he says that "We're working on it. We'll see if it's practical." Story
> A 50-cent vaccine developed at the Serum Institute of India-head by billionaire Cyrus Poonawalla--worked better than a standard jab from GlaxoSmithKline at protecting people from meningitis. Story
> Cubist Pharmaceuticals says it has gathered positive top-line results from the recently completed Phase II studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. Report
> Glasgow-based Lamellar Biomedical says that its lead drug for cystic fibrosis has won orphan drug status from the European Commission. Release
Pharma News
@FiercePharma: Sanofi moves deeper into Genzyme operations. Item | Follow @FiercePharma
> Are drugmakers suffering from complexity? Article
> Analysts eye survivors of $250B patent cliff. Article
> Restaurateurs join call to lift MA gift ban. Story
> J&J to exit stents, cut 1,000 jobs. Report
> FDA highlights cancer risk with Takeda's Actos. News
Vaccines News
> Immatics starts late-stage cancer vaccine study. News
> Type I diabetes nasal vaccine on the horizon. Item
> GSK boosts China presence with flu vaccine buyout. Story
> BiondVax releases promising Ph2 universal flu vax results. Article
> Cheap meningitis vax beats out GSK's version. Story
> GSK, Arecor form vaccine stabilization pact. Article
Manufacturing News
> Expert: FDA inadvertantly causing drug shortages. News
> APP expansion could help fight against drug shortages. Item
> Dr. Reddy's tarnished by FDA warning, fire probe. Story
> GSK deals to boost vax stability, fight flu in Asia. Report
> Fidelity mutual fund rides big pharma profits. Item
And Finally... In the back-and-forth argument over the potential link between cell phones and brain cancer, a new study covered by Reuters Health says that most tumors found in the brain are not within the radius of the radiation mobile phones emit. Report